Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility

Authors

  • Felipe A. Castro,

    Corresponding author
    1. Division of Genome Modifications and Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany
    2. Division of Cancer Epidemiology and Genetics, Infections & Immunoepidemiology Branch, National Cancer Institute, Rockville, MD
    • Division of Cancer Epidemiology and Genetics, Infections & Immunoepidemiology Branch, National Cancer Institute, Rockville, MD
    Search for more papers by this author
    • Fax: +1-301-402-0817

    • F.A.C. and E.L.I contributed equally to this work.

  • Emma L. Ivansson,

    1. Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
    Search for more papers by this author
    • F.A.C. and E.L.I contributed equally to this work.

  • Markus Schmitt,

    1. Division of Genome Modifications and Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Search for more papers by this author
  • Ivana Juko-Pecirep,

    1. Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
    Search for more papers by this author
  • Lennart Kjellberg,

    1. Department of Clinical Science, Obstetrics and Gynaecology, University of Umeå, Umeå, Sweden
    2. Department of Public Health and Clinical Medicine, University of Umeå, Umeå, Sweden
    Search for more papers by this author
  • Allan Hildesheim,

    1. Division of Cancer Epidemiology and Genetics, Infections & Immunoepidemiology Branch, National Cancer Institute, Rockville, MD
    Search for more papers by this author
  • Ulf B. Gyllensten,

    1. Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
    Search for more papers by this author
  • Michael Pawlita

    1. Division of Genome Modifications and Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Search for more papers by this author

  • This article is a US Government work and, as such, is in the public domain of the United States of America.

Abstract

Cervical cancer (CxCa) is caused by persistent human papillomavirus (HPV) infection; genetic predisposition is also suspected to play a role. Our study is a targeted candidate gene follow-up based on: (i) strong clinical evidence demonstrating that mutations in the TMC6 and TMC8 (EVER1 and EVER2) genes associate with the HPV-associated disease epidermodysplasia verruciformis (EV) and (ii) recent epidemiological data suggesting a genetic susceptibility conferred by polymorphisms in such genes for skin and CxCa. Clarifying the association of the TMC6/8 genes with risk of CxCa will help in understanding why some HPV-infected women develop persistent infection, cervical lesions and eventually cancer while others do not. Twenty-two single nucleotide polymorphisms (SNPs) harboring the TMC6/8 genes were genotyped in 2,989 cases with cervical intraepithelial neoplasia grade III or invasive CxCa and 2,281 controls from the Swedish population. Association was evaluated in logistic regression models. Two SNPs displayed association with cervical disease: rs2290907 [odds ratio (OR)GGvsAA = 0.6, 95% confidence interval (95% CI): 0.3–0.9, p = 0.02)] and rs16970849 (ORAGvsGG = 0.8, 95% CI: 0.66–0.98, p = 0.03). The present data support the involvement of the TMC6/8 region in CxCa susceptibility but further analyses are needed to replicate our findings, fully characterize the region and understand the function of the genetic variants involved.

Ancillary